For the year ending 2025-12-31, UHS had $46,570K increase in cash & cash equivalents over the period. $849,245K in free cash flow.
| Cash Flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Net income | 1,511,182 | 1,163,109 | 719,307 | 656,982 |
| Depreciation & amortization | 618,743 | 584,831 | 568,041 | 581,861 |
| Stock-based compensation expense | 95,688 | 99,349 | 87,720 | 85,378 |
| Unrealized gain on non-marketable securities | 93,291 | - | - | - |
| Loss (gain) on sales of assets and businesses | -7,968 | 9,920 | 6,250 | -584 |
| Costs related to extinguishment of debt | 0 | 3,158 | 0 | 0 |
| Provision for asset impairment | - | 0 | 0 | 57,550 |
| Accounts receivable | 317,985 | -67,355 | 182,444 | 258,338 |
| Accrued interest | 4,053 | -12,814 | -1,193 | -1,835 |
| Accrued and deferred income taxes | 21,441 | -12,651 | 43,450 | 29,510 |
| Other working capital accounts | -99,189 | -61,897 | 32,321 | 146,692 |
| Medicare accelerated payments and deferred cares act and other grants | - | - | -2,978 | -2,391 |
| Other assets and deferred charges | 28,599 | 12,163 | -48,517 | -19,918 |
| Other, net | 19,700 | 21,811 | 39,133 | -8,676 |
| Accrued insurance expense, net of commercial premiums paid | 236,771 | 254,394 | 183,462 | 174,723 |
| Payments made in settlement of self-insurance claims, net of commercial insurance reimbursements | 259,475 | - | - | - |
| Payments made in settlement of self-insurance claims | - | 192,185 | 118,089 | 141,983 |
| Deferred grant revenue | 0 | 0 | - | - |
| Net cash provided by operating activities | 1,864,397 | 2,067,101 | 1,267,797 | 996,023 |
| Property and equipment additions | 1,015,152 | 943,810 | 743,055 | 734,001 |
| Proceeds received from sales of assets and businesses | 15,863 | 38,563 | 24,187 | 12,001 |
| Acquisition of businesses and property | 47,804 | 18,998 | 3,728 | 20,309 |
| (outflows) inflows from foreign exchange contracts that hedge our net u.k. investment | 52,213 | -12,860 | 40,695 | -94,913 |
| Costs incurred for purchase and development of enterprise resource planning application | 24,695 | - | - | - |
| Proceeds received from sale of marketable equity securities | 63,073 | - | - | - |
| Costs incurred for purchase and implementation of information technology applications | - | - | 0 | 0 |
| Investments in non-marketable securities | 9,831 | - | - | - |
| Decrease in capital reserves of commercial insurance subsidiary | -142 | -276 | -16 | -100 |
| Investment in, and advances to, joint ventures and other | - | - | - | 0 |
| Net cash used in investing activities | -1,070,617 | -911,109 | -763,275 | -647,296 |
| Repayments of long-term debt | 43,504 | 2,640,001 | 85,480 | 89,367 |
| Additional borrowings | 285,536 | 2,210,248 | 185,100 | 705,321 |
| Financing costs | 382 | 12,566 | 308 | 3,164 |
| Repurchase of common shares | 967,951 | 670,754 | 547,363 | 832,918 |
| Dividends paid | 51,267 | 53,346 | 55,480 | 58,449 |
| Issuance of common stock | 16,729 | 15,070 | 13,654 | 14,068 |
| Profit distributions to noncontrolling interests | 11,734 | 6,508 | 6,830 | 5,391 |
| Purchase of ownership interests by minority members | 22,846 | 12,980 | 2,762 | -48,500 |
| Net cash used in financing activities | -749,727 | -1,144,877 | -493,945 | -318,400 |
| Effect of exchange rate changes on cash and cash equivalents | 2,517 | -833 | 3,056 | -8,424 |
| Increase in cash, cash equivalents and restricted cash | 46,570 | 10,282 | 13,633 | 21,903 |
| Cash, cash equivalents and restricted cash, beginning of period | 224,752 | 214,470 | 200,837 | 178,934 |
| Cash, cash equivalents and restricted cash, end of period | 271,322 | 224,752 | 214,470 | 200,837 |
UNIVERSAL HEALTH SERVICES INC (UHS)
UNIVERSAL HEALTH SERVICES INC (UHS)